#MEDIA: Announcing positive topline results from a Phase 3 trial evaluating a novel oral combination regimen for adult patients with relapsed or refractory multiple myeloma, as early as first relapse. bit.ly/4jF3JT6
Bristol Myers Squibb
@bmsnews
We work every day to transform patients’ lives through science. See our community guidelines: one.bms.com/3WHdbIG